Consulting with veterinarians across the country, Dr. Plant was concerned that the limitations of allergy testing were unnecessarily preventing many allergic pets from receiving immunotherapy. Significant issues concerning reliability, accuracy, and standardization of technique remained unresolved. Synthesizing the available evidence, Dr. Plant concluded that he could no longer recommend allergy testing as the basis for formulating immunotherapy. Rather, he created RESPIT®, which allows veterinarians to prescribe immunotherapy to counter the most important allergenic substances found in a geographic region, rather than relying on uncertain allergy test results.
SkinVet distributes RESPIT in the United States through a partnership with our USDA licensed manufacturer, Nelco Vet. SkinVet is actively seeking regulatory approval that will allow us to meet the requests from overseas veterinarians. If you are a distributor that is well-positioned to represent RESPIT in Europe, Australia, Canada, or Asia, we would welcome your inquiry.